Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |